Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Roche”
- A Study Evaluating Different Immunotherapies (LAG-3 and PD-1 With or Without TIGIT, Compared to PD-L1 Alone) in Participants With Untreated Locally Advanced Metastatic Urothelial CancerActive Not Recruiting
Sponsor: Hoffmann-La Roche
Urothelial Cancer
United States, Australia, Brazil, China, Denmark +10 more
Sponsor: Hoffmann-La Roche
Paroxysmal Nocturnal Hemoglobinuria
United States, Belgium, Brazil, Czechia, Estonia +19 more
- Safety and Efficacy Study of OpRegen for Treatment of Advanced Dry-Form Age-Related Macular DegenerationActive Not Recruiting
Sponsor: Hoffmann-La Roche
Age-Related Macular Degeneration
United States, Israel
- A Study to Evaluate Overall Health, Physical Activity, and Joint Outcomes in Participants With Severe or Moderate Hemophilia A Without Factor VIII Inhibitors on Emicizumab ProphylaxisActive Not Recruiting
Sponsor: Hoffmann-La Roche
Severe Hemophilia A · Moderate Hemophilia A
United States, Brazil, Canada, Germany, Hungary +7 more
Sponsor: Hoffmann-La Roche
Metastatic Breast Cancer
United States, Argentina, Australia, Belgium, Brazil +24 more
Sponsor: Hoffmann-La Roche
Rheumatoid Arthritis
United States, Argentina, Belgium, Brazil, Denmark +6 more
Sponsor: Washington University School of Medicine
Alzheimers Disease · Dementia · Alzheimers Disease, Familial
United States, Argentina, Australia, Brazil, Canada +10 more
Sponsor: Hoffmann-La Roche
Dry Eye Disease
United States
- A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab StudyActive Not Recruiting
Sponsor: Hoffmann-La Roche
Cancer
United States, Australia, Belgium, Brazil, Bulgaria +19 more
Sponsor: Memorial Sloan Kettering Cancer Center
Metastatic HER2-Positive Breast Cancer
United States
- A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)Active Not Recruiting
Sponsor: Hoffmann-La Roche
Multiple Sclerosis
United States, Argentina, Belgium, Brazil, Bulgaria +17 more
- Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid TumorsActive Not Recruiting
Sponsor: Institut Bergonié
Solid Tumor, Adult · Pancreatic Cancer · Virus-associated Tumors · Non Small Cell Lung Cancer
France
Sponsor: Institut Curie
Triple Negative Breast Cancer
France
- A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple SclerosisActive Not Recruiting
Sponsor: Hoffmann-La Roche
Progressive Multiple Sclerosis (PMS)
United States, Bosnia and Herzegovina, Brazil, Canada, Colombia +19 more
- AACR Adaptive Biomarker-Driven Organ Preservation Trial in Gastroesophageal AdenocarcinomasRecruiting
Sponsor: American Association for Cancer Research
Gastroesophageal Adenocarcinoma
United States, Canada
Sponsor: Hoffmann-La Roche
Esophageal Squamous Cell Carcinoma
United States, Argentina, Australia, Austria, Belgium +23 more
- Obinutuzumab for Systemic Lupus Erythematosus Pure Membranous Nephropathy: a Phase II TrialNot Yet Recruiting
Sponsor: Assistance Publique - Hôpitaux de Paris
Lupus Nephritis · Membranous Nephropathy
France
Sponsor: ETOP IBCSG Partners Foundation
Pleural Mesothelioma Malignant Advanced
Belgium, France, Italy, Spain, Switzerland +1 more
- Impact of Microglial Activation on Synaptic Density in Alzheimer's DiseaseActive Not Recruiting
Sponsor: Centre Hospitalier St Anne
Alzheimer Disease
France
- A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's DiseaseNot Yet Recruiting
Sponsor: Hoffmann-La Roche
Alzheimer's Disease
- ALEctinib for the Treatment of Pretreated RET-rearranged Advanced Non-small Cell Lung CancerTerminated
Sponsor: ETOP IBCSG Partners Foundation
Non-small Cell Lung Cancer · Non-small Cell Lung Cancer Metastatic · Non-small Cell Lung Cancer Recurrent
Belgium, Ireland, Italy, Netherlands, Spain +1 more
- A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With ISN/RPS 2003 Class III or IV Lupus NephritisActive Not Recruiting
Sponsor: Hoffmann-La Roche
Lupus Nephritis
United States, Argentina, Brazil, Colombia, France +10 more
- A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS)Active Not Recruiting
Sponsor: Hoffmann-La Roche
Atypical Hemolytic Uremic Syndrome
United States, Belgium, Brazil, Canada, China +11 more
Sponsor: Hoffmann-La Roche
Relapsing Remitting Multiple Sclerosis
United States, Germany, Spain
Sponsor: Hoffmann-La Roche
Non-small Cell Lung Cancer
United States, Australia, Belgium, Brazil, France +6 more